The Round Table serves as a forum for exchange between relevant stakeholders and connects key players from research, clinical practice, industry, politics and society. It brings together stakeholder representatives and spokespersons from the working groups of the National Strategy for Gene and Cell-based Therapies. The aim of the Round Table is to identify common needs, challenges and opportunities in the field of gene and cell-based therapies. The format promotes interdisciplinary exchange and lays the foundation for cooperation, coordinated strategies and future-oriented development.